Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects.
Buprenorphine in an extended-release formulation intended for use in laboratory subjects is frequently administered to rats to provide extended analgesia without repeated handling. While levels of buprenorphine may persist in serum once extended-release buprenorphine has been introduced, exposure to...
Main Authors: | Christina M Larson, Cecilia Barajas, Kelley F Kitto, George L Wilcox, Carolyn A Fairbanks, Cristina D Peterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0298819 |
Similar Items
-
Adeno-associated virus-mediated gene transfer of arginine decarboxylase to the central nervous system prevents opioid analgesic tolerance
by: Caroline C. Churchill, et al.
Published: (2024-02-01) -
Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States.
by: Janetta L Iwanicki, et al.
Published: (2016-01-01) -
Effectiveness of two extended-release buprenorphine formulations during postoperative period in neonatal rats.
by: Mingyun Zhang, et al.
Published: (2022-01-01) -
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
by: Mark K. Greenwald, et al.
Published: (2023-12-01) -
Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case series
by: Taylor A. Ochalek, et al.
Published: (2023-06-01)